☆ 4.5 Review

Corticosteroid therapy in acute respiratory distress syndrome

CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)

Journal

CANADIAN MEDICAL ASSOCIATION JOURNAL

Volume 185, Issue 3, Pages 216-221

Publisher

CMA-CANADIAN MEDICAL ASSOC

DOI: 10.1503/cmaj.120582

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Immunology

Lung Microbiota Signature and Corticosteroid Responses in Pneumonia-Associated Acute Respiratory Distress Syndrome in Hematological Patients

Jiawei Shen, Yan Hu, Jie Lv, Huiying Zhao, Bin Wang, Shuguang Yang, Anqi Du, Shuang Liu, Youzhong An

Summary: This study aimed to classify hematological patients with pneumonia-associated ARDS into different groups based on their responsiveness to corticosteroids, investigate the microbiota signatures of non-responders and responders, and compare their prognosis. The results showed that responders had higher ventilator free days compared to non-responders. Additionally, the microbiota signatures differed between the two groups. Non-responders with coinfections had the lowest survival rate.

JOURNAL OF INFLAMMATION RESEARCH (2022)

Add to Collection

Article Pharmacology & Pharmacy

The Controversy About the Effects of Different Doses of Corticosteroid Treatment on Clinical Outcomes for Acute Respiratory Distress Syndrome Patients: An Observational Study

Jia-Wei Yang, Ping Jiang, Wen-Wen Wang, Zong-Mei Wen, Bei Mao, Hai-Wen Lu, Li Zhang, Yuan-Lin Song, Jin-Fu Xu

Summary: Appropriate dosages of corticosteroids may improve oxygenation and moderately inhibit inflammation in ARDS patients. However, the risks associated with high-dose corticosteroid treatment should be carefully considered.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Molecular markers of type II alveolar epithelial cells in acute lung injury by bioinformatics analysis

Xiaoting Yang, Jing Wang, Wei Liu

Summary: In this study, molecular markers associated with type II alveolar epithelial cell injury in acute lung injury (ALI) were identified using bioinformatics methods. The results provide new insights for the diagnosis and treatment of ALI/ARDS.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Plant Sciences

Glycyrrhizin mitigates acute lung injury by inhibiting the NLRP3 inflammasome in vitro and in vivo

JunMei Wang, Chunxiu Ren, WenHui Bi, Wuliji Batu

Summary: Glycyrrhiza glabra L. is a widely used traditional Chinese medicine with various therapeutic effects. This study found that its active ingredient, glycyrrhizin, has anti-inflammatory effects and can alleviate acute lung injury (ALI) by interfering with the NF-κB/NLRP3 signaling pathway.

JOURNAL OF ETHNOPHARMACOLOGY (2023)

Add to Collection

Review Cell Biology

Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome

Chang Liu, Kun Xiao, Lixin Xie

Summary: This review discusses the pathogenesis of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and the biological characteristics and mechanisms of mesenchymal stromal cells (MSCs) in the treatment of ALI/ARDS.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome

Thomas S. Metkus, Lori J. Sokoll, Andreas S. Barth, Matthew J. Czarny, Allison G. Hays, Charles J. Lowenstein, Erin D. Michos, Eric P. Nolley, Wendy S. Post, Jon R. Resar, David R. Thiemann, Jeffrey C. Trost, Rani K. Hasan

Summary: The study found that over 50% of intubated patients with severe COVID-19 had myocardial injury, which was associated with a higher mortality rate. Myocardial injury in COVID-19 was closely related to baseline comorbidities, age, and multisystem organ dysfunction. Compared with ARDS patients without COVID-19, COVID-19 patients were older and had poorer cardiac function, but had a lower incidence of myocardial injury.

CIRCULATION (2021)

Add to Collection

Article Medicine, General & Internal

Renal Replacement Therapy in Patients with Influenza Pneumonia Related Acute Respiratory Distress Syndrome

Ko-Wei Chang, Shaw-Woei Leu, Shih-Wei Lin, Shinn-Jye Liang, Kuang-Yao Yang, Ming-Cheng Chan, Wei-Chih Chen, Han-Chung Hu, Wen-Feng Fang, Yu-Mu Chen, Chau-Chyun Sheu, Ming-Ju Tsai, Hao-Chien Wang, Ying-Chun Chien, Chung-Kan Peng, Chieh-Liang Wu, Kuo-Chin Kao

Summary: In patients with influenza pneumonia-related ARDS, the mortality rate is significantly higher in those requiring RRT for AKI than those not requiring RRT. Predictors for AKI requiring RRT include chronic liver disease and C-reactive protein, while predictors for mortality include pneumonia severity index, tidal volume, and continuous renal replacement therapy. Patients with ESRD did not show a significant difference in mortality compared to other patients.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Immunology

Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup

Huikang Xu, Shiying Sheng, Weiwei Luo, Xiaofang Xu, Zhaocai Zhang

Summary: Acute respiratory distress syndrome (ARDS) is a serious condition characterized by inflammatory lung injury and immune system disturbance. Researchers have used latent class analysis and targeted treatment to improve ARDS therapy, and sepsis-induced ARDS is particularly difficult to treat.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Effect of Different Corticosteroid Regimens on the Outcome of Severe COVID-19-Related Acute Respiratory Failure. A Retrospective Analysis

Michele Umbrello, Paolo Formenti, Stefano Nespoli, Eleonora Pisano, Cecilia Bonino, Stefano Muttini

Summary: Systemic corticosteroids, including dexamethasone and methylprednisolone, showed no significant difference in outcomes such as ICU stay duration, hospital mortality, and infectious complications. However, emergency, short-term, high-dose corticosteroid boluses were generally associated with worse outcomes. A subgroup of subjects receiving the boluses did show improved oxygenation and lower hospital mortality.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Association between antenatal corticosteroid use and perinatal mortality among preterm births in hospitals in Tanzania

Stanley Mwita, Eveline Konje, Benjamin Kamala, Angelina Izina, Semvua Kilonzo, Andrew Kigombola, Karol J. Marwa, Mary Jande, Deborah Dewey

Summary: The study found that exposure to antenatal corticosteroids (ACS) was associated with lower perinatal mortality rates among preterm infants in Tanzania. However, only about one-third of eligible women were provided with ACS, indicating low usage of ACS in this setting. Various factors were identified that influenced the low usage of ACS in this limited resource environment.

PLOS ONE (2021)

Add to Collection

Article Computer Science, Artificial Intelligence

An interpretable deep learning workflow for discovering subvisual abnormalities in CT scans of COVID-19 inpatients and survivors

Longxi Zhou, Xianglin Meng, Yuxin Huang, Kai Kang, Juexiao Zhou, Yuetan Chu, Haoyang Li, Dexuan Xie, Jiannan Zhang, Weizhen Yang, Na Bai, Yi Zhao, Mingyan Zhao, Guohua Wang, Lawrence Carin, Xigang Xiao, Kaijiang Yu, Zhaowen Qiu, Xin Gao

Summary: Knowledge on long-term complications of COVID-19 is limited, especially in CT scans of survivors. A deep learning-based method was developed to calculate an optimal window for each scan and remove irrelevant tissues, making subvisual abnormalities visible in lung CT scans.

NATURE MACHINE INTELLIGENCE (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Delivery systems of therapeutic nucleic acids for the treatment of acute lung injury/acute respiratory distress syndrome

Chuanyu Zhuang, Minji Kang, Minhyung Lee

Summary: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a life-threatening inflammatory lung disease, mainly caused by sepsis, infections, trauma, toxic reagents, and COVID-19. Current treatment options for ALI/ARDS are limited, but gene therapy using therapeutic nucleic acids has shown potential. Two classes of therapeutic nucleic acids, knock-in genes and oligonucleotides, have been developed for the treatment of ALI/ARDS. Delivery systems for efficient delivery of therapeutic nucleic acids into the lungs have also been explored. This review discusses ALI/ARDS gene therapy mainly in terms of delivery systems and provides insights for the development of new treatment strategies.

JOURNAL OF CONTROLLED RELEASE (2023)

Add to Collection

Article Critical Care Medicine

Plasma Nucleosomes Are Associated With Mortality in Pediatric Acute Respiratory Distress Syndrome

Nadir Yehya, Hossein Fazelinia, Gladys G. Lawrence, Lynn A. Spruce, Mark Mai, G. Scott Worthen, Jason D. Christie

Summary: This study found that plasma nucleosomes are associated with the severity of acute respiratory distress syndrome (ARDS) in children, as well as with nonpulmonary organ failures. Nucleosomes were also linked to higher mortality rates and fewer ventilator-free days in the pediatric ARDS patients. Proteomic analysis further showed elevated levels of core nucleosome histones in septic children with ARDS.

CRITICAL CARE MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

MicroRNAs: Important Regulatory Molecules in Acute Lung Injury/Acute Respiratory Distress Syndrome

Qianying Lu, Sifan Yu, Xiangyan Meng, Mingyu Shi, Siyu Huang, Junfeng Li, Jianfeng Zhang, Yangfan Liang, Mengjun Ji, Yanmei Zhao, Haojun Fan

Summary: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is an inflammatory response that destroys lung parenchymal cells and reduces lung function. MicroRNAs play a crucial role in regulating inflammatory and immune responses in ALI/ARDS and may serve as diagnostic indicators and therapeutic targets.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Medicine, Research & Experimental

Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome

Qianqian Li, Rui Li, Hanlin Yin, Suli Wang, Bei Liu, Jun Li, Mi Zhou, Qingran Yan, Liangjing Lu

Summary: This study evaluated the potential of IRAK4 inhibitors as a treatment for ARDS-cytokine release syndrome (CRS). The results showed that BAY-1834845 effectively prevented lung injury and improved existing ARDS when combined with dexamethasone. Compared to other drugs, BAY-1834845 reduced inflammatory cell infiltration and neutrophil count. Interestingly, BAY-1834845 preserved the signatures of naive lymphocytes and stromal cells.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Add to Collection

Article Medicine, General & Internal

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Karim Ali, Tanweer Azher, Mahin Baqi, Alexandra Binnie, Sergio Borgia, Francois M. Carrier, Yiorgos Alexandros Cavayas, Nicolas Chagnon, Matthew P. Cheng, John Conly, Cecilia Costiniuk, Peter Daley, Nick Daneman, Josh Douglas, Catarina Downey, Erick Duan, Emmanuelle Duceppe, Madeleine Durand, Shane English, George Farjou, Evradiki Fera, Patricia Fontela, Rob Fowler, Michael Fralick, Anna Geagea, Jennifer Grant, Luke B. Harrison, Thomas Havey, Holly Hoang, Lauren E. Kelly, Yoav Keynan, Kosar Khwaja, Gail Klein, Marina Klein, Christophe Kolan, Nadine Kronfli, Francois Lamontagne, Michael Lau, Todd C. Lee, Nelson Lee, Rachel Lim, Sarah Longo, Alexandra Lostun, Erika MacIntyre, Isabelle Malhame, Kathryn Mangoff, Marlee McGuinty, Sonya Mergler, Matthew Munan, Srinivas Murthy, Conar O'Neil, Daniel Ovakim, Jesse Papenburg, Ken Kuljit S. Parhar, Seema Nair Parvathy, Chandni Patel, Santiago Perez-Patrigeon, Ruxandra Pinto, Subitha Rajakumaran, Asgar Rishu, Malaika Roba-Oshin, Moira Rushton, Mariam Saleem, Marina Salvadori, Kim Scherr, Kevin Schwartz, Makeda Semret, Michael Silverman, Ameeta Singh, Wendy Sligl, Stephanie Smith, Ranjani Somayaji, Darrell H. S. Tan, Siobhan Tobin, Meaghan Todd, Tuong-Vi Tran, Alain Tremblay, Jennifer Tsang, Alexis Turgeon, Erik Vakil, Jason Weatherald, Cedric Yansouni, Ryan Zarychanski

Summary: This Canadian study explores the effectiveness of remdesivir as a treatment for COVID-19. The results show that remdesivir has a modest but significant impact on important outcomes for patients and healthcare systems, such as the need for mechanical ventilation.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2022)

Add to Collection

Letter Medicine, General & Internal

Unclear reporting of secondary outcome in randomized trial of Lv et al

Arnav Agarwal, Francois Lamontagne, Neill K. J. Adhikari

IRISH JOURNAL OF MEDICAL SCIENCE (2022)

Add to Collection

Article Biochemical Research Methods

Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19

Yassene Mohammed, David R. Goodlett, Matthew P. Cheng, Donald C. Vinh, Todd C. Lee, Allison Mcgeer, David Sweet, Karen Tran, Terry Lee, Srinivas Murthy, John H. Boyd, Joel Singer, Keith R. Walley, David M. Patrick, Curtis Quan, Sara Ismail, Laetitia Amar, Aditya Pal, Rayhaan Bassawon, Lara Fesdekjian, Karine Gou, Francois Lamontagne, John Marshall, Greg Haljan, Robert Fowler, Brent W. Winston, James A. Russell

Summary: This study conducted longitudinal proteomic analysis of acute-phase COVID-19 patients, revealing changes in lipid-associated functions, complement activation, humoral immune response, and acute inflammatory response-related proteins. The study also identified differentiated proteins between survivors and nonsurvivors.

JOURNAL OF PROTEOME RESEARCH (2022)

Add to Collection

Article Anesthesiology

The evolution of mean arterial pressure in critically ill patients on vasopressors before and during a trial comparing a specific mean arterial pressure target to usual care

Marie-Helene Masse, Neill K. J. Adhikari, Xavier Theroux, Marie-Claude Battista, Frederick D'Aragon, Ruxandra Pinto, Alan Cohen, Michael Mayette, Charles St-Arnaud, Michelle Kho, Michael Chasse, Martine Lebrasseur, Irene Watpool, Rebecca Porteous, M. Elizabeth Wilcox, Francois Lamontagne

Summary: In this study, we found that a lower mean arterial pressure target in an unblinded trial was not associated with a change in mean arterial pressure, indicating stability in the net effect of usual clinician practices over time.

BMC ANESTHESIOLOGY (2022)

Add to Collection

Review Health Care Sciences & Services

Administration of Parenteral Vitamin C in Patients With Severe Infection: Protocol for a Systematic Review and Meta-analysis

Arnav Agarwal, John Basmaji, Shannon M. Fernando, Fang Zhou Ge, Yingqi Xiao, Haseeb Faisal, Kimia Honarmand, Mathieu Hylands, Vincent Lau, Kimberley Lewis, Rachel Couban, Francois Lamontagne, Neill K. J. Adhikari

Summary: This study describes a protocol for a living systematic review that aims to evaluate the effectiveness and safety of parenteral vitamin C administration in adults with severe infections, including COVID-19 patients. The review will provide important insights for critical care physicians and hospitalists and may inform international clinical guidance. The review will be updated iteratively as new trial evidence becomes available.

JMIR RESEARCH PROTOCOLS (2022)

Add to Collection

Article Emergency Medicine

Pre- and posttransfer computed tomography imaging in Canadian trauma centers: A multicenter retrospective cohort study

Godwill Abiala, Melanie Berube, Eric Mercier, Natalie Yanchar, H. Thomas Stelfox, Patrick Archambault, Gilles Bourgeois, Amina Belcaid, Xavier Neveu, Chartelin J. Isaac, Julien Clement, Francois Lamontagne, Lynne Moore

Summary: The study results indicate that pretransfer CT and repeat posttransfer CT are frequent and subject to significant practice variation in trauma transfers. Additionally, pretransfer CT is associated with increased time to transfer. These findings suggest potential opportunities to reduce low-value imaging for trauma transfers.

ACADEMIC EMERGENCY MEDICINE (2022)

Add to Collection

Review Critical Care Medicine

Patient, Public, and Healthcare Professionals' Sepsis Awareness, Knowledge, and Information Seeking Behaviors: A Scoping Review

Kirsten M. Fiest, Karla D. Krewulak, Rebecca Brundin-Mather, Madison P. Leia, Alison Fox-Robichaud, Francois Lamontagne, Jeanna Parsons Leigh

Summary: The study revealed global variations in awareness and knowledge of sepsis among patients, the public, and healthcare professionals. Future research could benefit from a consistent definition and country-specific data to support targeted public awareness campaigns.

CRITICAL CARE MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Charlotte A. Bradbury, Patrick R. Lawler, Simon J. Stanworth, Bryan J. McVerry, Zoe McQuilten, Alisa M. Higgins, Paul R. Mouncey, Farah Al-Beidh, Kathryn M. Rowan, Lindsay R. Berry, Elizabeth Lorenzi, Ryan Zarychanski, Yaseen M. Arabi, Djillali Annane, Abi Beane, Wilma Van Bentum-Puijk, Zahra Bhimani, Shailesh Bihari, Marc J. M. Bonten, Frank M. Brunkhorst, Adrian Buzgau, Meredith Buxton, Marc Carrier, Allen C. Cheng, Matthew Cove, Michelle A. Detry, Lise J. Estcourt, Mark Fitzgerald, Timothy D. Girard, Ewan C. Goligher, Herman Goossens, Rashan Haniffa, Thomas Hills, David T. Huang, Christopher M. Horvat, Beverley J. Hunt, Nao Ichihara, Francois Lamontagne, Helen L. Leavis, Kelsey M. Linstrum, Edward Litton, John C. Marshall, Daniel F. McAuley, Anna McGlothlin, Shay P. McGuinness, Saskia Middeldorp, Stephanie K. Montgomery, Susan C. Morpeth, Srinivas Murthy, Matthew D. Neal, Alistair D. Nichol, Rachael L. Parke, Jane C. Parker, Luis Reyes, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Ary Serpa-Neto, Christopher W. Seymour, Manu Shankar-Hari, Vanessa Singh, Timo Tolppa, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Cameron Green, Roger J. Lewis, Derek C. Angus, Colin J. McArthur, Scott Berry, Lennie P. G. Derde, Steve A. Webb, Anthony C. Gordon

Summary: The study results showed that among critically ill patients with COVID-19, treatment with an antiplatelet agent compared with no antiplatelet agent did not significantly improve the number of organ support-free days within 21 days. The use of antiplatelet therapy in critically ill patients with COVID-19 did not show significant benefits.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Health Care Sciences & Services

A Machine-Learning Approach for Estimating Subgroup- and Individual-Level Treatment Effects: An Illustration Using the 65 Trial

Zia Sadique, Richard Grieve, Karla Diaz-Ordaz, Paul Mouncey, Francois Lamontagne, Stephen O'Neill

Summary: Personalizing treatment recommendations requires understanding the heterogeneity of treatment effects. Machine-learning approaches, such as causal forests, can explore this heterogeneity by considering multiple covariates. This study compares the causal forest method with parametric approaches and finds similar estimates of treatment effectiveness. The results suggest that the permissive hypotension strategy is expected to reduce mortality for most patients, but there is variability in the estimated effects.

MEDICAL DECISION MAKING (2022)

Add to Collection

Article Surgery

Quality Indicators Targeting Low-Value Clinical Practices in Trauma Care

Lynne Moore, Melanie Berube, Pier-Alexandre Tardif, Francois Lauzier, Alexis Turgeon, Peter Cameron, Howard Champion, Natalie Yanchar, Fiona Lecky, John Kortbeek, David Evans, Eric Mercier, Patrick Archambault, Francois Lamontagne, Belinda Gabbe, Jerome Paquet, Tarek Razek, Henry Thomas Stelfox

Summary: A set of evidence-based and patient-informed quality indicators targeting reductions in low-value clinical practices in acute, in-hospital trauma care was developed through a consensus study. These indicators can be used in trauma quality programs to measure and reduce low-value care in high-income countries.

JAMA SURGERY (2022)

Add to Collection

Article Health Care Sciences & Services

Lessening Organ Dysfunction With Vitamin C (LOVIT) Trial: Statistical Analysis Plan

Neill K. J. Adhikari, Ruxandra Pinto, Andrew G. Day, Marie-Helene Masse, Julie Menard, Sheila Sprague, Djillali Annane, Yaseen M. Arabi, Marie-Claude Battista, Dian Cohen, Deborah J. Cook, Gordon H. Guyatt, Daren K. Heyland, Salmaan Kanji, Shay P. McGuinness, Rachael L. Parke, Bharath Kumar Tirupakuzhi Vijayaraghavan, Emmanuel Charbonney, Michael Chasse, Lorenzo Del Sorbo, Demetrios James Kutsogiannis, Francois Lauzier, Remi Leblanc, David M. Maslove, Sangeeta Mehta, Armand Mekontso Dessap, Tina S. Mele, Bram Rochwerg, Oleksa G. Rewa, Jason Shahin, Pawel Twardowski, Paul Jeffrey Young, Francois Lamontagne

Summary: This study aims to describe a prespecified statistical analysis plan (SAP) for the LOVIT trial, which includes the primary and secondary outcomes and planned analysis methods. The primary outcome is a combination of mortality and persistent organ dysfunction at 28 days. The study will use a frequentist statistical framework and consider the impacts of different subgroups.

JMIR RESEARCH PROTOCOLS (2022)

Add to Collection

Article Medicine, General & Internal

Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit

Francois Lamontagne, Marie-Helene Masse, Julie Menard, Sheila Sprague, Ruxandra Pinto, Daren K. Heyland, Deborah J. Cook, Marie-Claude Battista, Andrew G. Day, Gordon H. Guyatt, Salmaan Kanji, Rachael Parke, Shay P. McGuinness, Bharath-Kumar Tirupakuzhi Vijayaraghavan, Djillali Annane, Dian Cohen, Yaseen M. Arabi, Brigitte Bolduc, Nicole Marinoff, Bram Rochwerg, Tina Millen, Maureen O. Meade, Lori Hand, Irene Watpool, Rebecca Porteous, Paul J. Young, Frederick D'Aragon, Emilie P. Belley-Cote, Elaine Carbonneau, France Clarke, David M. Maslove, Miranda Hunt, Michael Chasse, Martine Lebrasseur, Francois Lauzier, Sangeeta Mehta, Hector Quiroz-Martinez, Oleksa G. Rewa, Emmanuel Charbonney, Andrew J. E. Seely, Demetrios J. Kutsogiannis, Remi LeBlanc, Armand Mekontso-Dessap, Tina S. Mele, Alexis F. Turgeon, Gordon Wood, Sandeep S. Kohli, Jason Shahin, Pawel Twardowski, Neill K. J. Adhikari

Summary: A study on the use of intravenous vitamin C in adult sepsis patients receiving vasopressor therapy in the ICU showed that there is a higher risk of death or persistent organ dysfunction compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Critical Care Medicine

Monitoring and auditing protocol adherence, data integrity and ethical conduct of a randomized clinical trial: A case study

Alyson Takaoka, Nicole Zytaruk, Megan Davis, Andrea Matte, Jennie Johnstone, Francois Lauzier, John Marshall, Neill Adhikari, France J. Clarke, Bram Rochwerg, Francois Lamontagne, Lori Hand, Irene Watpool, Rebecca K. Porteous, Marie-Helene Masse, Frederick D'Aragon, Daniel Niven, Diane Heels-Ansdell, Erick Duan, Joanna Dionne, Shane English, Charles St-Arnaud, Tina Millen, Deborah J. Cook, PROSPECT Investigator, Canadian Critical Care Trials Grp

Summary: The purpose of this study was to categorize, quantify, and interpret findings documented in feedback letters from monitoring or auditing visits for a multicenter randomized trial. The results showed that most observations were related to training documentation and the informed consent process. There were minimal threats to data integrity, patient privacy, or safety.

JOURNAL OF CRITICAL CARE (2022)

Add to Collection

Article Medicine, Research & Experimental

Research interrupted: applying the CONSERVE 2021 Statement to a randomized trial of rehabilitation during critical illness affected by the COVID-19 pandemic

Julie C. Reid, Alex Molloy, Geoff Strong, Laurel Kelly, Heather O'Grady, Deborah Cook, Patrick M. Archambault, Ian Ball, Sue Berney, Karen E. A. Burns, Frederick D'Aragon, Erick Duan, Shane W. English, Francois Lamontagne, Amy M. Pastva, Bram Rochwerg, Andrew J. E. Seely, Karim Serri, Jennifer L. Y. Tsang, Avelino C. Verceles, Brenda Reeve, Alison Fox-Robichaud, John Muscedere, Margaret Herridge, Lehana Thabane, Michelle E. Kho

Summary: The COVID-19 pandemic has disrupted non-COVID critical care trials. This study uses the CONSERVE statement to report the impact of the pandemic on the CYCLE trial and describes the mitigation approaches.

TRIALS (2022)

Add to Collection

Article Respiratory System

Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study

Luis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, Mike Irvine, Laura Merson, Ignacio Martin-Loeches, Jordi Rello, Fabio S. Taccone, Robert A. Fowler, Annemarie B. Docherty, Christiana Kartsonaki, Irene Aragao, Peter W. Barrett, Abigail Beane, Aidan Burrell, Matthew Pellan Cheng, Michael D. Christian, Jose Pedro Cidade, Barbara Wanjiru Citarella, Christl A. Donnelly, Susana M. Fernandes, Craig French, Rashan Haniffa, Ewen M. Harrison, Antonia Ying Wai Ho, Mark Joseph, Irfan Khan, Michelle E. Kho, Anders Benjamin Kildal, Demetrios Kutsogiannis, Francois Lamontagne, Todd C. Lee, Gianluigi Li Bassi, Jose Wagner Lopez Revilla, Catherine Marquis, Jonathan Millar, Raul Neto, Alistair Nichol, Rachael Parke, Rui Pereira, Sergio Poli, Pedro Povoa, Kollengode Ramanathan, Oleksa Rewa, Jordi Riera, Sally Shrapnel, Maria Joao Silva, Andrew Udy, Timothy Uyeki, Steve A. Webb, Evert-Jan Wils, Amanda Rojek, Piero L. Olliaro

Summary: This study investigated the clinical outcomes of severe COVID-19 patients treated outside the ICU, compared to those treated in the ICU. It found that patients admitted to an ICU had a longer hospital stay and a lower 28-day fatality ratio.

ERJ OPEN RESEARCH (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.